VSTM News
Archived Headlines
- 2012 IPO calendar building with 10 deals planned, pre-IPO research available 01/18/12
- Biopharmaceutical maker Verastem starts US roadshow, looks to raise $45 million 01/13/12
- Technology leads a week of 5 new US IPO filings, 5 IPOs added to the calendar 01/13/12
- Verastem files for a $50 million IPO 11/03/11
Busy pricing period ahead after 7 companies set terms last week
While the mere possibility of a Facebook filing grabbed all the headlines, actual filings continued to flow in, as seven companies set terms for their IPOs. There are now ...read more
Verastem prices upsized IPO at $10 midpoint
Verastem, a pre-clinical stage biotech developing stem cell therapies for metastatic cancers, raised $55 million by offering 5.5 million shares at $10, the midpoint of the range of $9 to $11. Verastem plans to list on the NASDAQ under the symbol VSTM. UBS...read more
3 U.S. IPOs planned for the week of Jan 23
The following IPOs are expected to price this week:
Guidewire Software (GWRE), which provides enterprise software and services to 103 P&C insurers, plans to raise...read more
2012 IPO calendar building with 10 deals planned, pre-IPO research available
In the past three trading days, six companies have moved forward on their IPOs, bringing the total number of scheduled IPOs to 10. Renewable Energy Group (REGI) will kick off the 2012 IPO...read more